Literature DB >> 2723435

Variations in protein expression related to human eosinophil heterogeneity.

V Gruart1, J M Balloul, L Prin, M Tomassini, S Loiseau, A Capron, M Capron.   

Abstract

In hypereosinophilic patients, eosinophil heterogeneity has been assessed mainly according to morphologic and biologic criteria. In order to investigate the molecular basis of such heterogeneity, biochemical analysis was performed on various eosinophil subpopulations fractionated on metrizamide gradients. Whole cell extracts from purified eosinophils disrupted with a nonionic (NP-40) detergent were successively analyzed by SDS-PAGE and two-dimensional electrophoresis (isoelectric focusing or nonequilibrium pH gradient electrophoresis in the first dimension). Hypodense eosinophils that sediment in the lightest density gradients (18 to 22% metrizamide solution) differed from other purified eosinophils (intermediate and normodense eosinophils respectively collected in 22 to 23% and 23 to 25% metrizamide solutions). Comparative analysis of protein patterns on both monodimensional and bidimensional electrophoresis showed that a basic protein of Mr 51 kDa, present on normodense or intermediate eosinophils, was poorly detected in the case of hypodense eosinophils. In contrast, two other proteins with apparent Mr of about 23 kDa and 41 kDa were exclusively or predominantly identified in these latter cell fractions. Immunochemical analysis with polyclonal antibodies against eosinophil basic proteins and enzymatic assays revealed that the 51-kDa polypeptide could be related to an eosinophil peroxidase-like molecule. In addition, the two proteins detected only in hypodense eosinophils might be related to proteins newly synthesized by in vivo activated eosinophils. Our results suggest that variations in protein expression might represent a good marker of in vivo activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723435

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.

Authors:  W F Owen; J Petersen; K F Austen
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Toward the Proteome of the Human Peripheral Blood Eosinophil.

Authors:  Christof Straub; Konrad Pazdrak; Travis W Young; Susan J Stafford; Zheng Wu; John E Wiktorowicz; Anthony M Haag; Robert D English; Kizhake V Soman; Alexander Kurosky
Journal:  Proteomics Clin Appl       Date:  2009       Impact factor: 3.494

3.  Mature eosinophils stimulated to develop in human-cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. II. Vesicular transport of specific granule matrix peroxidase, a mechanism for effecting piecemeal degranulation.

Authors:  A M Dvorak; S J Ackerman; T Furitsu; P Estrella; L Letourneau; T Ishizaka
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

4.  Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.

Authors:  A M Dvorak; T Furitsu; L Letourneau; T Ishizaka; S J Ackerman
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

5.  Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor.

Authors:  J Chihara; J Plumas; V Gruart; J Tavernier; L Prin; A Capron; M Capron
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.